Monitor upcoming 10-Q for Q3 2026 to see the first full quarter of results under the new segment structure, particularly BSI BIOS and BSI BMID margins.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 6 $61.31entry
- T+1 · 8d ago +8.53%α +6.16% · $66.54
- T+5 · 4d ago +0.46%α −2.14% · $61.59
- T+6 · todayOpen
- T+20 · in 20d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Bruker filed an 8-K to disclose a reorganization of its reportable segments effective July 1, 2026, and provided recast segment financials for historical periods. The new segments are BSI BIOS, BSI Microbiology and Infection Diagnostics (BMID), BSI NANO, and BEST. The recast data does not change consolidated results.
Key Facts
- Effective July 1, 2026, Bruker reorganized from four segments (BSI BioSpin, BSI CALID, BSI NANO, BEST) to four new segments (BSI BIOS, BSI BMID, BSI NANO, BEST).
- BSI BIOS combines the former BioSpin, SciY, Chemspeed Technologies, Daltonics, Optics, and Mimetas divisions.
- BSI BMID consists of the Microbiology, Molecular Diagnostics, and Biomedical Systems divisions (formerly part of BSI CALID).
- BSI NANO and BEST segments were unchanged.
- The recast segment information covers FY2024, FY2025, Q1-Q3 2025, and Q1-Q2 2026, with no impact on consolidated results.
- Total consolidated revenue for the six months ended June 30, 2026 was $1,661.9 million (recast), compared to $1,598.8 million for the same period in 2025.
Financial Impact
No direct financial impact; recast data shows consolidated revenue of $1,661.9M for H1 2026 vs $1,598.8M for H1 2025, a 3.9% increase.
Risk Factors
- No material risks identified; this is a routine segment realignment disclosure.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-449782 |
| Document: brkr-20261105.htm | 0001193125-26-449782 |
| Document: 0001193125-26-449782-index-headers.html | 0001193125-26-449782 |
| Document: 0001193125-26-449782-index.html | 0001193125-26-449782 |
| Document: 0001193125-26-449782.txt | 0001193125-26-449782 |
Track record
10 reports on BRKR
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 16, 2026today 8-K Neutral 2/10 Entry price pending
- Nov 6, 202610d ago Institutional Cluster Neutral 3/10 Entry $61.31 Now $60.62 −1.13% settles Feb 4
- Nov 5, 202611d ago 8-K Neutral 2/10 Viewing Entry $61.31 Now $60.62 −1.13% settles Feb 4
- Nov 4, 202612d ago 8-K Neutral 5/10 Entry $63.79 Now $60.62 −4.97% settles Feb 2
- Oct 29, 202618d ago 8-K Neutral 2/10 Entry $57.07 Now $60.62 +6.22% settles Jan 28
- Oct 27, 202620d ago Institutional Cluster Mixed 4/10 Entry $62.00 Now $60.62 −2.23% settles Jan 26
- Aug 18, 202612w ago Insider Cluster Neutral 2/10 Entry $58.60 to $62.41 Now $60.62 +3.44% ▲ +6.50% +7.32% vs SPY
- Aug 14, 202613w ago 8-K Neutral 2/10 Entry $57.67 to $62.24 Now $60.62 +5.12% ▲ +7.92% +10.87% vs SPY
- Aug 4, 202614w ago 8-K Bullish 7/10 Entry $50.30 to $60.74 Now $60.62 +20.52% ▲ +20.76% +20.97% vs SPY
- Jun 11, 202622w ago Institutional Cluster Mixed 4/10 Entry $55.18 to $58.50 Now $60.62 +9.86% ▲ +6.02% +1.62% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers